Hydrochloric Acid

Hydrochloric Acid

SCHEMBL67458

CC(O)N(C)C.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1007647 0.96
Trimethylammonium SCHEMBL28154322 0.96 ALDH1A1 (0.39)
SCHEMBL14112035 0.95
SCHEMBL5944 0.95
SCHEMBL9389522 0.91
Lithium SCHEMBL1395029 0.91
Iodide SCHEMBL1832780 0.91
Bromide SCHEMBL313669 0.91
SCHEMBL21407669 0.91
Ammonia Solution, Strong SCHEMBL7070777 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2337 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119822483-A Method for degrading perfluorinated compounds in sludge 广东工业大学 2025-04-15 CN claimed
CN-116063585-B Modified temperature-resistant guanidine gum and preparation method thereof 中海油田服务股份有限公司 2024-08-20 CN claimed
EP-4388070-A1 WATER-SOLUBLE FILMS AND METHODS OF USE Nohbo, Inc. (US) 2024-06-26 EP claimed
CN-118043441-A Compositions and their use in cleaning applications 智能流体有限公司 2024-05-14 CN claimed
CN-116715265-A Superfine BaSO 4 /TiO 2 Preparation method of composite material 晋中学院 2023-09-08 CN claimed
CN-116675993-A Preparation method of titanium dioxide modified superfine barium sulfate powder 晋中学院 2023-09-01 CN claimed
US-11717481-B2 Reduction of flake-like aggregation in nanoparticulate active agent compositions ALKERMES PHARMA IRELAND LIMITED (IE) 2023-08-08 US claimed
CN-116063585-A Modified temperature-resistant guanidine gum and preparation method thereof 中海油田服务股份有限公司 2023-05-05 CN claimed
WO-2023023493-A1 WATER-SOLUBLE FILMS AND METHODS OF USE NOHBO, INC. (US) 2023-02-23 WO claimed
US-20220211626-A1 REDUCTION OF FLAKE-LIKE AGGREGATION IN NANOPARTICULATE ACTIVE AGENT COMPOSITIONS JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT 2022-07-07 US claimed
WO-2000040687-A1 FABRIC CARE COMPOSITION CONTAINING A PROTEIN THE PROCTER & GAMBLE COMPANY (US) 2000-07-13 WO claimed
CN-1225120-A Detergent compositions comprising improved amylases, cellulase and cationic surfactant PROCTER & GAMBLE (US) 1999-08-04 CN claimed
EP-0912688-A1 DETERGENT COMPOSITIONS COMPRISING IMPROVED AMYLASES, CELLULASE AND CATIONIC SURFACTANT THE PROCTER & GAMBLE COMPANY (US) 1999-05-06 EP claimed
CN-1206433-A Stable high perfume, low active fabric softener compositions PROCTER & GAMBLE (US) 1999-01-27 CN claimed
EP-0791015-A4 CATIONIC POLYMER PROCTER & GAMBLE (US) 1998-08-26 EP claimed
WO-1997043386-A1 DETERGENT COMPOSITIONS COMPRISING IMPROVED AMYLASES, CELLULASE AND CATIONIC SURFACTANT THE PROCTER & GAMBLE COMPANY (US) 1997-11-20 WO claimed
EP-0791015-A1 CATIONIC POLYMER THE PROCTER & GAMBLE COMPANY (US) 1997-08-27 EP claimed
WO-1996015154-A1 CATIONIC POLYMER THE PROCTER & GAMBLE COMPANY (US) 1996-05-23 WO claimed
EP-0582624-A1 CATIONIC POLYSACCHARIDES. ANGELINI CONSORT RICERCHE (IT) 1994-02-16 EP claimed
WO-1992019652-A1 CATIONIC POLYSACCHARIDES SOCIETÀ CONSORTILE RICERCHE ANGELINI S.P.A. (IT) 1992-11-12 WO claimed